Methodological Approaches to Risk Management of Advanced Therapy Medicinal Products
Introduction. Advanced therapy medicinal products (ATMPs) rely on recent advances in medical science, but alongside with potential benefits they may also bring safety concerns for patients. The inherent complexity of the ATMP production and use calls for special approaches to risk management through...
Saved in:
| Main Authors: | A. A. Taube, N. Yu. Velts |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-09-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1564 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adoptive cell therapy for cancer: combination strategies and biomarkers
by: Shiyu Liu, et al.
Published: (2025-08-01) -
Cell-based medicinal products: a review of current research
by: E. V. Galitsyna, et al.
Published: (2024-12-01) -
Nutrient-gene therapy as a strategy to enhance CAR T cell function and overcome barriers in the tumor microenvironment
by: Brandon Park, et al.
Published: (2025-06-01) -
Autologous engineered T cell receptor therapy in advanced cancer
by: Apostolia M. Tsimberidou, et al.
Published: (2023-12-01) -
Tumor-infiltrating lymphocyte therapy: therapeutic advances and prospects
by: Sarker Drishty Badhon, et al.
Published: (2025-01-01)